Drug recall · December 27, 2017
Methylphenidate Hydrochloride Extended-release Tablets recall
Why: Subpotent Drug
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Methylphenidate Hydrochloride Extended-release Tablets, USP 54 mg, 100-count bottles, Rx Only, Trigen Laboratories, LLC. Bridgewater, NJ 08807, NDC 13811-709-10
- Lots / codes
Lot #: 170029A, Exp. 02/2019; 170030A, Exp. 02/2019
- Quantity
- 9919 bottles
- Company
- Osmotica Pharmaceutical Corp, Marietta, GA
- Distribution
- Nationwide
- Initiated
- December 18, 2017 · Voluntary: Firm initiated
- Classified
- December 20, 2017
- Reported
- December 27, 2017
- Ended
- May 1, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Methylphenidate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.